Search - tctmd.com

Displaying 101 - 120 of 3270

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Plant-Derived Compound Shows Early Promise for Small AAAs

L.A. McKeown

April 25, 2025

News Daily News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Yael L. Maxwell

April 24, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Daily News

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Todd Neale

April 23, 2025

News Daily News

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Caitlin E. Cox

April 17, 2025

News Featured Fellow

Aditya Mehta, MBBS

Yael L. Maxwell

April 10, 2025

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

L.A. McKeown

April 10, 2025

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

News Conference News EHRA 2025

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Todd Neale

April 08, 2025

News Conference News ACC 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

Yael L. Maxwell

April 07, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Caitlin E. Cox

March 21, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Caitlin E. Cox

March 05, 2025

News Daily News

Veterans Health System Meets—or Bests—Community Care for CVD

Caitlin E. Cox

March 03, 2025

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

Advertisement

Plant-Derived Compound Shows Early Promise for Small AAAs

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Aditya Mehta, MBBS

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

What’s Going to Be Hot at ACC 2025?

March 2025 Dispatch for the CV Team

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Veterans Health System Meets—or Bests—Community Care for CVD

Pi-Cardia Reports First Commercial Cases with ShortCut™

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content